Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye
Launched by AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO "G. MARTINO" · Mar 7, 2017
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
Introduction:
Dry eye disease (DED) is a common eye condition causing burden on visual function and reducing quality of life and work productivity. DED is a tear film disorder resulting in hyperosmolarity of tear film and inflammation of ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. This condition provokes traumatisms caused by the movement of the eyelids on the ocular surface and an insufficient cleansing of the same by microbial agents and/or foreign bodies.
Prevalence of DED increases wi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 18 and 80 years,
- • history of at least 3 months of dry eye symptoms referable to mild to moderate dry eye.
- Exclusion Criteria:
- • presence of any ocular disease, present or past, other than dry eye;
- • previous ocular surgery,
- • use of contact lens or topic treatments other than tear substitutes;
- • presence of systemic diseases requiring a treatment with systemic drugs potentially interfering with tear productions;
- • hypersensitivity to the active substance or to excipients;
- • participation in a clinical trial during the 3 months prior to the beginning of the study,
- • pregnancy or breast-feeding.
About Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Azienda Ospedaliera Universitaria Policlinico "G. Martino" is a leading academic hospital located in Messina, Italy, dedicated to providing high-quality healthcare and advancing medical research. As a prominent clinical trial sponsor, the institution integrates cutting-edge clinical practices with rigorous scientific inquiry, facilitating innovative studies that aim to enhance patient outcomes. With a commitment to excellence in patient care, education, and research, the hospital collaborates with multidisciplinary teams and stakeholders to drive forward the frontiers of medical science, ensuring that their trials adhere to the highest ethical and regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Pasquale Aragona, MD
Principal Investigator
Azienda Ospedaliera Universitaria Policlinico "G. Martino", Messina, Italy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials